C

China Biologic Products, Inc

13 employees

Taibang Biologic Group is a Chinese biopharmaceutical company that provides a comprehensive range of plasma-derived products.

Basic info

pharmaceutical manufacturing

Biotechnology

Pharmaceutical

Biopharma

Medical

Health Care

2002

$590M

from 7 investors over 7 rounds

C

China Biologic Products, Inc raised $300M on August 2, 2022

Investors: Cinda Securities, Abu Dhabi Investment Authority (ADIA) and GIC

C

China Biologic Products, Inc raised $590M on August 27, 2018

Investors: Hillhouse Capital Management, Centurium Capital and CITIC Capital

C

China Biologic Products, Inc raised undisclosed on December 1, 2015

Investors: IDG Capital Partners